Alpesh Nakrani

Devlyn AI · .NET · Biotech

.NET engineering for Biotech. Shipped at 4× pace.

Deploy a senior .NET pod that understands Biotech compliance natively. One retainer. Embedded in your team in 24 hours.

The intersection

Operating .NET in Biotech is not just a syntax problem — it is an architectural and compliance challenge.

.NET pods typically ship enterprise services with ASP.NET Core for high-performance REST and gRPC APIs, Azure-anchored backends leveraging Azure Functions, Service Bus, and Cosmos DB for cloud-native architectures, Blazor full-stack apps using WebAssembly or Server-Side rendering for interactive web UIs without JavaScript, and integration platforms connecting legacy .NET Framework systems with modern microservices through gradual migration patterns. Devlyn engineers ship .NET with EF Core for database access with compiled queries and split-query optimisation, MediatR and CQRS patterns for clean command-query separation, OpenTelemetry for distributed tracing, and modern minimal-API conventions for lightweight endpoint definitions — with production-grade performance profiling using BenchmarkDotNet and memory diagnostics.

AI-augmented .NET workflows lean on Cursor and Claude Code for controller and minimal-API endpoint scaffolding with proper model validation, EF Core entity configuration with Fluent API relationship mapping, migration authoring with proper data-seed handling, MediatR handler patterns for commands and queries with pipeline behaviours, and integration-test generation using WebApplicationFactory — all under senior validation that owns architecture decisions, EF Core query performance tuning (query plan analysis, N+1 detection, compiled queries), security review on ASP.NET Core Identity and authorization policy configuration, and .NET-specific patterns like dependency-injection lifetime management, middleware ordering, and background-service lifecycle management with IHostedService. Compression shows up strongest in endpoint scaffolding, EF Core configuration, and test infrastructure.

Book a discovery call →

Browse how this exact .NET and Biotech combination maps to different talent markets.

.NET · Biotech · New York

.NET for Biotech in New York

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Eastern (ET) calendar, fte-only paths to scale engineering in nyc routinely run 2–3 quarters behind the roadmap.

Read the full brief →

.NET · Biotech · San Francisco

.NET for Biotech in San Francisco

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Pacific (PT) calendar, fte hiring in sf has slowed structurally since 2024 layoffs but compensation expectations have not.

Read the full brief →

.NET · Biotech · Los Angeles

.NET for Biotech in Los Angeles

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Pacific (PT) calendar, la's hiring funnel competes with sf for senior talent at lower compensation envelopes.

Read the full brief →

.NET · Biotech · Boston

.NET for Biotech in Boston

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Eastern (ET) calendar, boston fte pipelines run 4–6 months for senior backend roles.

Read the full brief →

.NET · Biotech · Chicago

.NET for Biotech in Chicago

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Central (CT) calendar, chicago fte hiring runs 3–5 months for senior roles with reasonable base salaries vs coast hubs.

Read the full brief →

.NET · Biotech · Seattle

.NET for Biotech in Seattle

The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. .NET pods compress the work — . On the Pacific (PT) calendar, seattle fte pipelines compete with faang-tier salaries that startup budgets cannot match.

Read the full brief →

Common questions

  • Why hire a .NET pod specifically for Biotech?

    Because .NET in Biotech requires specific architectural patterns. undefined Devlyn's pods bring both the deep .NET ecosystem knowledge and the Biotech regulatory context on day one.

  • What does the .NET pod own end-to-end?

    Architecture, security review, and the .NET-specific patterns that production-grade work requires. .NET pods typically ship enterprise services with ASP.NET Core for high-performance REST and gRPC APIs, Azure-anchored backends leveraging Azure Functions, Service Bus, and Cosmos DB for cloud-native architectures, Blazor full-stack apps using WebAssembly or Server-Side rendering for interactive web UIs without JavaScript, and integration platforms connecting legacy .NET Framework systems with modern microservices through gradual migration patterns. Devlyn engineers ship .NET with EF Core for database access with compiled queries and split-query optimisation, MediatR and CQRS patterns for clean command-query separation, OpenTelemetry for distributed tracing, and modern minimal-API conventions for lightweight endpoint definitions — with production-grade performance profiling using BenchmarkDotNet and memory diagnostics.

  • How do AI-augmented workflows help in Biotech?

    AI-augmented .NET workflows lean on Cursor and Claude Code for controller and minimal-API endpoint scaffolding with proper model validation, EF Core entity configuration with Fluent API relationship mapping, migration authoring with proper data-seed handling, MediatR handler patterns for commands and queries with pipeline behaviours, and integration-test generation using WebApplicationFactory — all under senior validation that owns architecture decisions, EF Core query performance tuning (query plan analysis, N+1 detection, compiled queries), security review on ASP.NET Core Identity and authorization policy configuration, and .NET-specific patterns like dependency-injection lifetime management, middleware ordering, and background-service lifecycle management with IHostedService. Compression shows up strongest in endpoint scaffolding, EF Core configuration, and test infrastructure. In Biotech, this compression is particularly valuable for accelerating The most common biotech engineering trap is treating an audit trail as an afterthought rather than a core architectural component, leading to failed FDA inspections and blocked drug approvals. Second is building data pipelines that cannot scale to modern genomic sequence sizes. Devlyn pods design immutable event-sourced audit logs and highly parallelized data processing. without compromising the compliance posture.

  • What is the typical shape of this engagement?

    .NET engagements at Devlyn typically run as one senior backend engineer plus shared DevOps for $5,000–$9,000/month, covering service architecture, EF Core entity design, and Azure deployment pipeline. This scales to a two- or three-engineer pod when the roadmap splits into parallel lanes across enterprise-integration work (connecting legacy .NET Framework systems), Blazor frontend development, and Azure-platform infrastructure including Functions, Service Bus, and Cosmos DB management. Pods share a single retainer with flexible allocation. undefined

Scope the work

If your Biotech roadmap is shaped, book a 30-minute discovery call. We will validate if a .NET pod is the right fit, and if not, what shape is.